{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:25:37Z","timestamp":1786119937927,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1097\/inf.0b013e3182293a82","type":"journal-article","created":{"date-parts":[[2011,7,9]],"date-time":"2011-07-09T08:32:40Z","timestamp":1310200360000},"page":"e216-e224","source":"Crossref","is-referenced-by-count":12,"title":["Combined Haemophilus Influenzae Type B-Neisseria Meningitidis Serogroup C Vaccine Is Immunogenic and Well Tolerated in Preterm Infants When Coadministered With Other Routinely Recommended Vaccines"],"prefix":"10.1097","volume":"30","author":[{"given":"F\u00e9lix","family":"Ome\u00f1aca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Ar\u00edstegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Tejedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Moreno-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9sus","family":"Ruiz-Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Manuel","family":"Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Muro Brussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1s","family":"S\u00e1nchez-Tamayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Castro Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Cabanillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavitha","family":"Peddiraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narcisa","family":"Mesaros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-35-20210202","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1542\/peds.112.1.193","article-title":"Immunization of preterm and low birth weight infants. American Academy of Pediatrics Committee on Infectious Diseases.","volume":"112","author":"Saari","year":"2003","journal-title":"Pediatrics"},{"key":"R2-35-20210202","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s004310050739","article-title":"Vaccination strategies for children with specific medical conditions: a paediatrician's viewpoint.","volume":"156","author":"Siegrist","year":"1997","journal-title":"Eur J Pediatr"},{"key":"R3-35-20210202","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1542\/peds.2004-2336","article-title":"Response of preterm newborns to immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated polio and Haemophilus influenzae type b vaccine: first experiences and solutions to a serious and sensitive issue.","volume":"116","author":"Ome\u00f1aca","year":"2005","journal-title":"Pediatrics"},{"key":"R4-35-20210202","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/adc.86.6.396","article-title":"The UK Hib vaccine experience.","volume":"86","author":"Heath","year":"2002","journal-title":"Arch Dis Child"},{"key":"R5-35-20210202","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1086\/318132","article-title":"Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood.","volume":"31","author":"Heath","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R6-35-20210202","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1016\/j.vaccine.2007.04.018","article-title":"Immunogenicity, safety and tolerability of meningococcal C CRM197 conjugate vaccine administered 3, 5 and 11 months post-natally to pre- and full-term infants.","volume":"25","author":"Esposito","year":"2007","journal-title":"Vaccine"},{"key":"R7-35-20210202","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/01.inf.0000187027.45918.6a","article-title":"Immunogenicity and immunologic memory of meningococcal C conjugate vaccine in premature infants.","volume":"24","author":"Collins","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R8-35-20210202","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1086\/324666","article-title":"Immune response of premature infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae type b conjugate vaccines.","volume":"184","author":"Slack","year":"2001","journal-title":"J Infect Dis"},{"key":"R9-35-20210202","first-page":"2010","article-title":"Hepatitis B response of premature infants after primary and booster immunisation with a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus\/Haemophilus influenzae type B vaccine.","volume":"802503","author":"Ome\u00f1aca","year":"2010","journal-title":"Infect Dis Obstet Gynecol"},{"key":"R10-35-20210202","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/INF.0b013e318124a9c8","article-title":"Antibody persistence and booster vaccination during the second and fifth years of life in a cohort of children who were born prematurely.","volume":"26","author":"Ome\u00f1aca","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R11-35-20210202","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/infdis\/168.3.663","article-title":"Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines.","volume":"168","author":"Granoff","year":"1993","journal-title":"J Infect Dis"},{"key":"R12-35-20210202","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0022-3476(05)80424-X","article-title":"Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines.","volume":"120","author":"Decker","year":"1992","journal-title":"J Pediatr"},{"key":"R13-35-20210202","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1086\/314753","article-title":"Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory.","volume":"179","author":"Richmond","year":"1999","journal-title":"J Infect Dis"},{"key":"R14-35-20210202","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/CVI.00420-08","article-title":"Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom.","volume":"16","author":"Southern","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"R15-35-20210202","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(99)04377-9","article-title":"Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis.","volume":"354","author":"Eskola","year":"1999","journal-title":"Lancet"},{"key":"R16-35-20210202","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1185\/03007990152673837","article-title":"Haemophilus influenzae type b vaccine: reconstitution of lyophilised PRP-T vaccine with a pertussis-containing paediatric combination vaccine, or a change in the primary series immunisation schedule, may modify the serum anti-PRP antibody responses.","volume":"17","author":"Vidor","year":"2001","journal-title":"Curr Med Res Opin"},{"key":"R17-35-20210202","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1542\/peds.2005-2907","article-title":"Antipolyribosyl ribitol phosphate response of premature infants to primary and booster vaccination with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus\/Haemophilus influenzae type b vaccine.","volume":"119","author":"Ome\u00f1aca","year":"2007","journal-title":"Pediatrics"},{"key":"R18-35-20210202","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/INF.0b013e31813429fa","article-title":"A new combination Haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants.","volume":"26","author":"Pace","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R19-35-20210202","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/adc.2007.136036","article-title":"A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial.","volume":"93","author":"Pace","year":"2008","journal-title":"Arch Dis Child"},{"key":"R20-35-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.inf.0000247070.60063.09","article-title":"Immunogenicity and reactogenicity of primary immunization with a novel combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine coadministered with a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus vaccine at 2, 4 and 6 months.","volume":"26","author":"Tejedor","year":"2007","journal-title":"Pediatr Infect Dis. J"},{"key":"R21-35-20210202","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/CVI.00377-06","article-title":"Immunogenicity, reactogenicity, and immune memory after primary vaccination with a novel Haemophilus influenzae\u2013Neisseria meningitidis serogroup C conjugate vaccine.","volume":"14","author":"Schmitt","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"R22-35-20210202","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/INF.0b013e31820013d2","article-title":"Immediate and longer term immunogenicity of a single dose of the combined Haemophilus influenzae type b-Neisseria meningitidis serogroup c-tetanus toxoid conjugate vaccine in Hib-primed toddlers aged 12 to 18 months.","volume":"30","author":"Booy","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R23-35-20210202","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/INF.0b013e31816b4561","article-title":"Immunogenicity and reactogenicity of a booster dose of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine given to toddlers of 13\u201314 months of age with antibody persistence up to 31 months of age.","volume":"27","author":"Tejedor","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R24-35-20210202","doi-asserted-by":"crossref","first-page":"640","DOI":"10.4161\/hv.6.8.12154","article-title":"Combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C (HibMenC) or serogroup C and Y-tetanus toxoid conjugate (and HibMenCY) vaccines are well-tolerated and immunogenic when administered according to the 2, 3, 4 months schedule with a fourth dose at 12\u201318 months of age.","volume":"6","author":"Habermehl","year":"2010","journal-title":"Hum Vaccin"},{"key":"R25-35-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3476(70)80038-5","article-title":"Clinical assessment of gestational age in the newborn infant.","volume":"77","author":"Dubowitz","year":"1970","journal-title":"J Pediatr"},{"key":"R26-35-20210202","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group.","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"R27-35-20210202","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection\u2013serum bactericidal antibody activity.","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"},{"key":"R28-35-20210202","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England.","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"R29-35-20210202","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/infdis\/147.6.1100","article-title":"The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b.","volume":"147","author":"K\u00e4yhty","year":"1983","journal-title":"J Infect Dis"},{"key":"R30-35-20210202","first-page":"299","article-title":"Vaccines. 4th ed.","author":"Mast","year":"2004"},{"key":"R31-35-20210202","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/infdis\/149.6.1034","article-title":"The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b.","volume":"149","author":"Anderson","year":"1984","journal-title":"J Infect Dis"},{"key":"R32-35-20210202","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I","article-title":"Interval estimation for the difference between independent proportions: comparison of eleven methods.","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"key":"R33-35-20210202","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/adc.2004.052720","article-title":"DT5aP-Hib-IPV and MCC vaccines: preterm infants' response to accelerated immunisation.","volume":"90","author":"Slack","year":"2005","journal-title":"Arch Dis Child"},{"key":"R34-35-20210202","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s004310050797","article-title":"Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations.","volume":"157","author":"Schmitt","year":"1998","journal-title":"Eur J Pediatr"},{"key":"R35-35-20210202","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00006454-200108000-00010","article-title":"Haemophilus influenzae type b disease: impact and effectiveness of diphtheria-tetanus toxoids-acellular pertussis (-inactivated poliovirus)\/H. influenzae type b combination vaccines.","volume":"20","author":"Schmitt","year":"2001","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0b013e3182293a82","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:32:03Z","timestamp":1786044723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201111000-00035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3182293a82","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}